Search | IOVS | ARVO Journals

Showing 1 – 20 of 32

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Exploratory optical coherence tomography (OCT) analysis in patients with geographic atrophy (GA) treated by OpRegen: Results from the Phase 1/2a trial

Eyal Banin; Adiel Barak; David S Boyer; Rita Ehrlich; Allen Ho; Tareq Jaouni; Richard McDonald; Christopher D Riemann; David G Telander; Miao Zhang; Dolly Chang; Avi Ben-Shabat; Gary Hogge; Benjamin Reubinoff

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2826.

ARVO Annual Meeting Abstract June 2022

Safety and Efficacy of a Phase 1/2a Clinical Trial of Transplanted Allogeneic Retinal Pigmented Epithelium (RPE, OpRegen) Cells in Advanced Dry Age-Related Macular Degeneration (AMD)

Allen C Ho; Eyal Banin; Adiel Barak; David S Boyer; Rita Ehrlich; Tareq Jaouni; H Richard MacDonald; Christopher D Riemann; David Telander; Jordi Mones; Avi Ben Shabat; Gary S Hogge; Benjamin Reubinoff

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1862.

ARVO Annual Meeting Abstract June 2021

Phase I/IIa Clinical Trial of Transplanted Allogeneic Retinal Pigmented Epithelium (RPE, OpRegen) Cells in Advanced Dry Age-Related Macular Degeneration (AMD): Interim Results

Christopher D Riemann; Eyal Banin; Adiel Barak; David S Boyer; Rita Ehrlich; Allen Ho; Tareq Jaouni; Richard McDonald; David Telander; Jordi Mones; Joyce Velez; Gary S. Hogge; Benjamin Reubinoff

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3316.

ARVO Annual Meeting Abstract June 2020

Phase I/IIa Clinical Trial of Human Embryonic Stem Cell (hESC)-Derived Retinal Pigmented Epithelium (RPE, OpRegen) Transplantation in Advanced Dry Form Age-Related Macular Degeneration (AMD): Interim Results

Christopher D Riemann; Eyal Banin; Adiel Barak; David S Boyer; Rita Ehrlich; Tareq Jaouni; Richard McDonald; David Telander; Michael Keane; Jessica Ackert; Mark D. Ferguson; Avi Ben- Shabat; Jordi Mones; Diana Angelini; Gary S. Hogge; Benjamin Reubinoff

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):865.

ARVO Annual Meeting Abstract June 2020

Myo/Nog cells are present in membranes from patients with proliferative vitreoretinopathy

Nathan Morrison; Lindsay Gugerty; Jacquelyn V Gerhart; David Telander; Arturo Bravo-Nuevo; Mindy George-Weinstein

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3055.

Retina June 2016

Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes

PDF

David G. Telander; Alfred K. Yu; Krisztina I. Forward; Shawn A. Morales; Lawrence S. Morse; Susanna S. Park; Lynn K. Gordon
TAGS: epiretinal membrane, epithelium, proteins, tissue membrane, vitreoretinopathy, proliferative, immunohistochemistry
Invest. Ophthalmol. Vis. Sci.. 2016; 57(7):3112-3117. https://doi.org/10.1167/iovs.15-17791

ARVO Annual Meeting Abstract June 2015

Differentially expressed microRNAs in serum of patients with wet and dry AMD

Anthony T Nguyen; Zeljka Smit-McBride; Amar P Patel; David Telander; Lawrence S Morse

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):812.

ARVO Annual Meeting Abstract June 2015

In Vivo Gene Expression Profiling of the RPE/Choroid Following Intravitreal Steroid Injections Shows Alteration of Circadian Rhythm and Neurotransmitter Signaling

Elad Moisseiev; Zeljka Smit-McBride; Sara Modjtahedi; David Telander; Leonard M Hjelmeland; Lawrence S Morse

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):226.

ARVO Annual Meeting Abstract April 2014

Circulatory MicroRNAs in Serum as Potential Biomarkers for AMD

Anthony T Nguyen; Zeljka Smit-McBride; Matthew Bordbari; Amar P Patel; David Gregory Telander; Lawrence S Morse

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1328.

ARVO Annual Meeting Abstract April 2014

Retinal and RPE Autoimmunity in AMD: Assessment of Correlation with Degree of Response to Ranibizumab Therapy

Amar P Patel; Charles E Thirkill; David Gregory Telander; Kang Zhang; Zeljka Smit-McBride; Lawrence S Morse

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):67.

Retinal Cell Biology March 2013

Epithelial Membrane Protein 2 Controls VEGF Expression in ARPE-19 Cells

PDF

Shawn A. Morales; David G. Telander; Deanna Leon; Krisztina Forward; Jonathan Braun; Madhuri Wadehra; Lynn K. Gordon
TAGS: vascular endothelial growth factor a, membrane proteins, epithelium
Invest. Ophthalmol. Vis. Sci.. 2013; 54(3):2367-2372. https://doi.org/10.1167/iovs.12-11013

Retina March 2013

The Comparative Histologic Effects of Subthreshold 532- and 810-nm Diode Micropulse Laser on the Retina

PDF

Alfred K. Yu; Kevin D. Merrill; Steven N. Truong; Krisztina M. Forward; Lawrence S. Morse; David G. Telander
TAGS: lasers, retina, light coagulation
Invest. Ophthalmol. Vis. Sci.. 2013; 54(3):2216-2224. https://doi.org/10.1167/iovs.12-11382

ARVO Annual Meeting Abstract March 2012

GSTM1 and GSTM5 Polymorphisms in AMD Patients

Allan A. Hunter, III; Paul Spechler; David Telander; Joshua Dunaief

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2932.

ARVO Annual Meeting Abstract March 2012

Dasatinib inhibits experimental PVR progression

Shawn A. Morales; David G. Telander; Alfred K. Yu; Krisztina I. Forward; Jonathan Braun; Lynn K. Gordon

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):899.

ARVO Annual Meeting Abstract March 2012

Gene Profiling Of Retinal Gene Expression After Intravitreal Anti- Vegf Injections In Mice

Saadia Rashid; Zeljka Smit-McBride; David G. Telander; Allan A. Hunter, III; Lawrence S. Morse

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3326.

ARVO Annual Meeting Abstract March 2012

Epithelial Membrane Protein 2 (EMP2) Modulates Hypoxia-Inducible Factor 1α (Hif-1α and VEGF Expression by ARPE-19 Cells

Ann M. Chan; Shawn A. Morales; David G. Telander; Madhuri Wadehra; Lynn K. Gordon

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4778.

ARVO Annual Meeting Abstract March 2012

Ocular Safety of Dasatinib in a Rabbit Model

Alfred K. Yu; Shawn A. Morales; Krisztina I. Forward; Lynn K. Gordon; David G. Telander

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5357.

ARVO Annual Meeting Abstract March 2012

Inflammatory Reactions Complicating Exudative Age-Related Macular Degeneration (AMD)

Alena Reznik; Charles H. Weber; David G. Telander; Lawrence S. Morse; Susanna S. Park; Charles E. Thirkill

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6465.

ARVO Annual Meeting Abstract March 2012

Analysis And Comparison Of Human Circulatory MicroRNA Profiles Of Aqueous And Vitreous Humour From Normal Eyes vs. Those With Diabetic Retinopathy or AMD

Zeljka Smit-McBride; Saadia Rashid; Alfred K. Yu; Susanna S. Park; Leonard M. Hjelmeland; David G. Telander; Lawrence S. Morse

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2438.

Retina February 2012

Long-Term Effects of Intravitreal Injection of GMP-Grade Bone-Marrow–Derived CD34 + Cells in NOD-SCID Mice with Acute Ischemia-Reperfusion Injury

PDF

Susanna S. Park; Sergio Caballero; Gerhard Bauer; Bradley Shibata; Alan Roth; Paul G. Fitzgerald; Krisztina I. Forward; Ping Zhou; Jeannine McGee; David G. Telander; Maria B. Grant; Jan A. Nolta
TAGS: cd34 antigens, eye, intravitreal injections, mice, reperfusion injury, severe combined immunodeficiency, bone marrow, good manufacturing practice
Invest. Ophthalmol. Vis. Sci.. 2012; 53(2):986-994. https://doi.org/10.1167/iovs.11-8833

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Exploratory optical coherence tomography (OCT) analysis in patients with geographic atrophy (GA) treated by OpRegen: Results from the Phase 1/2a trial

Safety and Efficacy of a Phase 1/2a Clinical Trial of Transplanted Allogeneic Retinal Pigmented Epithelium (RPE, OpRegen) Cells in Advanced Dry Age-Related Macular Degeneration (AMD)

Phase I/IIa Clinical Trial of Transplanted Allogeneic Retinal Pigmented Epithelium (RPE, OpRegen) Cells in Advanced Dry Age-Related Macular Degeneration (AMD): Interim Results

Phase I/IIa Clinical Trial of Human Embryonic Stem Cell (hESC)-Derived Retinal Pigmented Epithelium (RPE, OpRegen) Transplantation in Advanced Dry Form Age-Related Macular Degeneration (AMD): Interim Results

Myo/Nog cells are present in membranes from patients with proliferative vitreoretinopathy

Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes

Differentially expressed microRNAs in serum of patients with wet and dry AMD

In Vivo Gene Expression Profiling of the RPE/Choroid Following Intravitreal Steroid Injections Shows Alteration of Circadian Rhythm and Neurotransmitter Signaling

Circulatory MicroRNAs in Serum as Potential Biomarkers for AMD

Retinal and RPE Autoimmunity in AMD: Assessment of Correlation with Degree of Response to Ranibizumab Therapy

Epithelial Membrane Protein 2 Controls VEGF Expression in ARPE-19 Cells

The Comparative Histologic Effects of Subthreshold 532- and 810-nm Diode Micropulse Laser on the Retina

GSTM1 and GSTM5 Polymorphisms in AMD Patients

Dasatinib inhibits experimental PVR progression

Gene Profiling Of Retinal Gene Expression After Intravitreal Anti- Vegf Injections In Mice

Epithelial Membrane Protein 2 (EMP2) Modulates Hypoxia-Inducible Factor 1α (Hif-1α and VEGF Expression by ARPE-19 Cells

Ocular Safety of Dasatinib in a Rabbit Model

Inflammatory Reactions Complicating Exudative Age-Related Macular Degeneration (AMD)

Analysis And Comparison Of Human Circulatory MicroRNA Profiles Of Aqueous And Vitreous Humour From Normal Eyes vs. Those With Diabetic Retinopathy or AMD

Long-Term Effects of Intravitreal Injection of GMP-Grade Bone-Marrow–Derived CD34 + Cells in NOD-SCID Mice with Acute Ischemia-Reperfusion Injury

To View More...

You must be signed into an individual account to use this feature.